2014 Chrysler Town & Country Touring on 2040-cars

Auto blog

Autoblog Podcast #380

Episode #380 of the Autoblog podcast is here, and this week, Dan Roth, Chris Paukert and Seyth Miersma talk about the Fiat-Chrysler five-year plan, the seeming demise of the Nissan Cube, and proposed legislation to require speed limiters with a 68-mph maximum on America's tractor trailers. We start with what's in the garage and finish up with some of your questions, and for those of you who hung with us live on our UStream channel, thanks for taking the time. Check out the new rundown below with times for topics, and you can follow along down below with our Q&A. Thanks for listening! Autoblog Podcast #380: Topics: Fiat-Chrysler five-year plan Nissan Cube on the way out? Big rig speed limiters coming? In the Autoblog Garage: 2015 Mercedes-Benz S63 AMG 2014 Chevrolet Sonic RS Sedan 2014 Honda Odyssey Touring Elite Hosts: Dan Roth, Chris Paukert, Seyth Miersma Runtime: 01:44:17 Rundown: Intro and Garage - 00:00 Fiat Chrysler Plan - 29:40 Nissan Cube - 01:07:33 Semi Speed Limiters - 01:17:33 Q&A - 01:27:35 Get the podcast: [UStream] Listen live on Mondays at 10 PM Eastern at UStream [iTunes] Subscribe to the Autoblog Podcast in iTunes [RSS] Add the Autoblog Podcast feed to your RSS aggregator [MP3] Download the MP3 directly Feedback: Email: Podcast at Autoblog dot com Review the show in iTunes Auto News Earnings/Financials Plants/Manufacturing Podcasts Rumormill Chevrolet Chrysler Dodge Fiat Jeep Nissan nissan cube speed limiters

2021 Chrysler Pacifica First Drive | More features, better van

Ever since its introduction as a 2017 model, the Chrysler Pacifica has been one of our favorite minivans. It offers stylish looks inside and out, traditional minivan practicality, excellent infotainment and some of the most compelling powertrain options. For its 2021 model year refresh, the Pacifica smartly expands on all the things we already enjoyed and avoids ruining any inherent goodness, as evidenced by our test van, a new-for-'21 Pinnacle trim level. The Pacifica’s changes start on the outside with redesigned front and rear fascias. These changes are probably the least successful, by which we mean, theyÂ’re not bad, just different. The modest grille and simple bumper design have given way to a deeper main grille and large lower openings, plus a pronounced air dam. It gives the van a wider, lower and meaner look. We donÂ’t dislike it, but it seems different rather than better. We do like the revamped tail with its full-width taillights. And if for some reason you prefer the previous design, the entry-level Chrysler Voyager is just a decontented Pacifica with the old styling. Under the skin, the biggest change is the addition of all-wheel drive, something not shared with the Voyager. The feature has been absent from the Chrysler van lineup for several years, since Chrysler couldnÂ’t fit a driveshaft between the underfloor wells for the Stow ‘n Go second-row seats. That issue has been solved, and now you can have AWD without sacrificing any interior seating flexibility. The AWD system can send all power to the rear wheels as needed, and it also can disconnect the rear driveshaft to increase fuel economy. Our test Pacifica was equipped with all-wheel drive, and it was certainly effective in some of metro DetroitÂ’s snowy conditions, offering a bit more launch traction and some assistance powering out of slow corners. But in the dry, it doesnÂ’t change the driving experience at all. Also, despite the ability to disengage the rear driveshaft, fuel economy still takes a hit compared to the front-drive model, dropping from 19 mpg in town and 28 on the highway, to 17 in the city and 25 on the highway. That's a difference of 2 mpg combined, which works out to be $150 per year in annual fuel costs, according to the EPA.

Fiat Chrysler says it did not know about Marchionne's illness

ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.